Skip to content
← Full study record

NCT03450057 · MORE INFO

Limitations, agreements, and source contact

Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment · Source last updated 2024-03-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
None reported.
point Of Contact
email
eterpos@med.uoa.gr
organization
General Hospital of Athens 'Alexandra', Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine
phone
+302102162540
title
Prof. Evangelos Terpos
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
None reported.
point Of Contact
email
eterpos@med.uoa.gr
organization
General Hospital of Athens 'Alexandra', Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine
phone
+302102162540
title
Prof. Evangelos Terpos

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice